Cerus Corporation

CERS Healthcare Medical Devices

Revenue
+6.28%
EPS
−2,800.0%
Free cash flow
+2,471.3%
Total debt
−25.4%

Quarter to September 2026, against a year earlier

2.03 0.10 −4.69%
Market cap
$430.2M
P/E
0.0×
Fwd P/E
−65.1×
Dividend yield
—
F-score
5/9
Altman Z
−4.00
Beneish M
−2.87
Dividend safety
n/a
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Piotroski F-Score
5 5 4 4 3 5 3 5 4 4
P/S ratio
1.68 1.41 2.08 3.51 7.31 9.93 6.29 8.78 7.51 11.23
Altman Z-Score
(4.00) (4.94) (4.87) (3.24) (0.54) 0.35 (4.12) (1.55) (7.17) (3.92)
P/FCF ratio
354.35 33.35 0.00 52.87 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z″-Score (non-manufacturers)
(13.54) (14.46) (15.30) (14.03) (11.03) (10.58) (15.80) (12.89) (22.72) (19.22)
Beneish M-Score
(2.87) (3.35) (2.22) (2.52) (2.51) (2.66) (1.34) (3.05) (2.44) (2.82)
P/Operating CF
63.33 57.66 (25.65) (376.01) (954.51) (127.46) (71.77) (94.08) (38.39) (45.40)
P/B ratio
6.04 5.00 7.29 9.63 13.62 10.93 10.34 7.90 9.89 7.63
EV/Sales
1.68 1.43 2.16 3.33 6.94 9.18 5.85 7.62 7.01 9.90
EV/EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/FCF
355.26 33.79 (8.44) 50.28 (31.77) (24.16) (7.37) (17.90) (6.84) (7.18)
Current Ratio
1.73 2.39 2.14 1.45 2.38 3.06 2.55 2.79 3.89 3.50
Net Debt/EBITDA
(0.14) (0.30) (0.51) 1.04 1.31 1.55 0.65 1.64 0.55 0.88
Debt/Equity
1.29 1.48 1.49 1.02 0.81 0.46 0.78 0.35 0.77 0.34
ROE
(25.65%) (37.92%) (61.45%) (55.49%) (57.41%) (74.42%) (100.65%) (93.25%) (125.27%) (82.47%)
ROA
(7.39%) (10.49%) (18.03%) (18.78%) (23.70%) (30.94%) (43.31%) (43.99%) (60.07%) (51.80%)
ROIC
(8.22%) (14.67%) (27.87%) (58.82%) (119.11%) (199.05%) (262.55%) 0.00% (447.11%) (693.97%)
Return on Tangible Assets
(18.88%) (21.89%) (43.82%) (66.78%) (45.03%) (43.59%) (76.88%) (56.24%) (87.95%) (89.61%)
Average Days of Receivables
47.42 53.99 69.37 66.73 57.50 67.62 65.71 42.00 88.29 63.83
Earnings Yield
(3.89%) (7.08%) (9.58%) (6.68%) (4.55%) (5.20%) (12.32%) (8.68%) (15.73%) (14.32%)
Free Cash Flow Yield
0.28% 3.00% (12.27%) 1.89% (2.99%) (3.83%) (12.61%) (4.85%) (13.65%) (12.27%)
Free Cash Flow per Share
0.01 0.05 (0.26) 0.07 (0.20) (0.26) (0.53) (0.25) (0.49) (0.53)
Book value per Share
0.34 0.31 0.30 0.39 0.50 0.63 0.41 0.64 0.36 0.57
Free Cash Flow
1.11 8.52 (47.76) 12.49 (34.83) (43.43) (74.43) (32.39) (52.59) (54.09)
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026